Moreover, if periodontal treatment is given to such cases, it may lead to the reduction of the C3 complement cleavage rate in human GCF [20]. In preclinical study models, the use of complement inhibitors for the treatment of periodontal disease has been recently demonstrated, and these models highlighted the positive and beneficial effects on the treatment of periodontal diseases. The gene discussed is C3; the disease is periodontal disorder.